相关实验视频
Updated: Sep 14, 2025

06:31
Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
3.2K
在寻找"最佳护理"的过程中,应该在哪里进行先天性隔膜的治疗?
Jessica C Pollack1, Tim Jancelewicz1, Yigit S Guner2
1Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, TN, USA.
Seminars in fetal & neonatal medicine
|July 23, 2025
概括
先天性隔膜 (CDH) 管理因医院而异,影响患者的治疗结果. 本次审查考察了机构因素,并提出了改善新生儿护理质量的建议.
科学领域:
- 新生儿手术 新生儿手术
- 儿科重症监护 儿科重症监护
- 医疗服务研究 医疗服务研究
背景情况:
- 在医疗机构之间,先天性隔膜 (CDH) 管理协议有很大差异.
- 这些中心特定实践的变化越来越多地与患者治疗结果的差异有关.
- 对于CDH来说,体外生命支持 (ECLS) 是资源密集型的,强调了机构和区域因素的重要性.
研究的目的:
- 审查有关影响CDH患者结果的机构因素的现有文献.
- 探索先天性腹膜的管理中中心水平变化的复杂性.
- 确定研究和质量改善举措,以提高CDH新生儿的治疗结果.
主要方法:
- 对先天性腹膜管理研究的系统文献综述.
- 分析影响患者结果的机构和区域因素.
- 综合有关中心特定实践及其影响的数据.
主要成果:
- 机构之间先天性隔膜 (CDH) 管理策略存在显著差异.
- 具体的中心实践,包括使用体外生命支持 (ECLS),明显影响患者的结果.
- 机构资源和多学科专业知识在优化对高风险新生儿的护理方面发挥着关键作用.
结论:
- 在各个机构中标准化先天性隔膜 (CDH) 管理协议至关重要.
- 需要进一步的研究和有针对性的质量改进举措,以减少结果的变化.
- 优化中心级因素可以改善CDH新生儿的生存率和长期健康状况.
相关概念视频
Flail Chest-II
236
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
236
Mitral Stenosis III: Medical Management
23
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
23
Mitral Stenosis IV: Nursing Management
47
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
47
Mitral Valve Prolapse III: Nursing Management
36
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
36
Cystic Fibrosis: Management
224
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
224
Esophageal Perforation-II: Clinical Manifestations and Management
149
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
149

